Prostate Cancer Care Disparity Analysis Project (ProGAP)

NCT06612034 | Recruiting

• 1 other identifier: ANKARA-UNIVERSITY-YURUN-01
• Study Type: observational
• Target: 400
• Locations: 1 country
• Sites: 1

Brief Summary

This international cross-sectional study seeks to evaluate global disparities in prostate cancer management by conducting a thorough comparison of key elements across countries categorized as low-income, lower-middle-income, upper-middle-income, and high-income. The primary question it addresses is: Are the standards of care for prostate cancer uniformly applied across different geographic regions worldwide? To achieve this, we will recruit physicians specializing in the diagnosis and treatment of prostate cancer from a diverse array of countries within these income classifications. Participants will complete a 17-question online survey.

Conditions

Prostate CA

Keywords

prostate cancer; Human Development Index; survey; access to medicine; multidisciplinary care

Outcome Measures

Primary Outcomes (1)

• Characterization of global disparities in prostate cancer diagnosis, treatment, and management practices

  Comparative analyses will be conducted using survey data to reveal disparities between different regions and healthcare settings. The findings will be presented as percentages of respondents, with territorial and institutional differences thoroughly evaluated. Participants will be categorized into three groups based on the World Bank\'s income classification: low and lower-middle, upper-middle, and high-income countries. Descriptive statistics will be employed to compare demographic characteristics and clinical practices. For categorical data analysis, the Pearson Chi-Square or Fisher\'s Exact test will be utilized, while ANOVA tests will be applied to independent variables. A p-value of less than 0.05 will be considered statistically significant.

  One month

Secondary Outcomes (1)

• Assessment of access to care, encompassing advanced diagnostic tools, treatment modalities, and patient support services; analysis of adherence to guidelines and its effect on treatment outcomes

  One month

Study Arms (1)

Healthcare professionals for prostate cancer

Healthcare professionals actively engaged in prostate cancer treatment, including urologists, uro-oncologists, medical oncologists, and radiation oncologists

Other: No Intervention: Observational Cohort

Interventions

No Intervention: Observational Cohort OTHER

No Intervention: Observational Cohort

Healthcare professionals for prostate cancer

Eligibility Criteria

• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Healthcare professionals actively treating prostate cancer patients-such as urologists, uro-oncologists, medical oncologists, and radiation oncologists-who specialize in the diagnosis and treatment of prostate cancer, representing a diverse range of countries categorized as low-income, lower-middle-income, upper-middle-income, and high-income

You may qualify if:

• Urologists, Uro-oncologists, Medical oncologists, Radiation oncologists

You may not qualify if:

• Non-clinical healthcare professionals Healthcare professionals not directly involved in the care of prostate cancer patients, Healthcare professionals with missing or incorrect email addresses

Sponsors & Collaborators

• Ankara University: lead

Study Sites (1)

Ankara University Faculty of Medicine

Ankara, Ankara, 06590, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Prostatic Neoplasms

Condition Hierarchy (Ancestors)

Genital Neoplasms, Male; Urogenital Neoplasms; Neoplasms by Site; Neoplasms; Genital Diseases, Male; Genital Diseases; Urogenital Diseases; Prostatic Diseases; Male Urogenital Diseases

Study Officials

• Yüksel Ürün

  Ankara University

  STUDY DIRECTOR

• Deborah Mukherji

  Clemenceau Medical Center Hospital Dubai

  STUDY DIRECTOR

• Mohammed Shahait

  Al Zahra Hospital Dubai

  STUDY DIRECTOR

• Luis Castelo Branco

  IOSI Oncologist Institute of Southern Switzerland

  STUDY DIRECTOR

Central Study Contacts

Yüksel Ürün

CONTACT

800-555-5555; yukselurun@gmail.com

Satı Coşkun Yazgan

CONTACT

800-555-5555; coskunyazgann491@gmail.com

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Target Duration: 1 Day
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor doctor

Study Record Dates

• First Submitted: September 21, 2024
• First Posted: September 25, 2024
• Study Start: March 10, 2025
• Primary Completion: October 30, 2025
• Study Completion: October 30, 2025
• Last Updated: July 24, 2025

Record last verified: 2024-09

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)